Stock Reports Stock Report Get our Stock Alerts before anyone else! Sign Up Today, it is totally free: Email Send Featured FB · FB – Need to Know: Facebook's been one of the strongest FAANGs this year. Here's why it's just been downgraded. August 23, 2021 11:07 am·The FAANG grouping of stocks haven’t really had much in common this year, with performance ranging from a 58% surge in Google parent Alphabet GOOG,… Read more Featured NGCA · NGCA – Virgin Orbit, a Responsive Launch and Space Solutions Company, to Become Publicly Traded on Nasdaq Through a Business Combination With NextGen Acquisition Corp. II Stock Report · TGT – Top Toy Ready: Target Announces Most Exclusives Ever and Disney Expansion Ahead of Holiday Season BBY · BBY – What To Expect From Best Buy's Stock Post Q2 Release? KAR · KAR – KAR to Accelerate Dealer-to-Dealer Growth, Profitability Through Acquisition of CARWAVE GKOS · GKOS – Glaukos Announces Market-Leading Clinical Milestone of 200 Peer-Reviewed Publications on iStent® Technologies BMY · BMY – U.S. Food and Drug Administration Accepts for Priority Review Bristol Myers Squibb's Application for Orencia (abatacept) for the Prevention of Acute Graft Versus Host Disease (aGvHD) Page 1 Page 2 Page 3 Page 4 Page 5Next →
FB – Need to Know: Facebook's been one of the strongest FAANGs this year. Here's why it's just been downgraded. August 23, 2021 11:07 am·The FAANG grouping of stocks haven’t really had much in common this year, with performance ranging from a 58% surge in Google parent Alphabet GOOG,… Read more
NGCA · NGCA – Virgin Orbit, a Responsive Launch and Space Solutions Company, to Become Publicly Traded on Nasdaq Through a Business Combination With NextGen Acquisition Corp. II
Stock Report · TGT – Top Toy Ready: Target Announces Most Exclusives Ever and Disney Expansion Ahead of Holiday Season
GKOS · GKOS – Glaukos Announces Market-Leading Clinical Milestone of 200 Peer-Reviewed Publications on iStent® Technologies
BMY · BMY – U.S. Food and Drug Administration Accepts for Priority Review Bristol Myers Squibb's Application for Orencia (abatacept) for the Prevention of Acute Graft Versus Host Disease (aGvHD)